Form D · Pharmaceuticals

Aridis Pharmaceuticals, Inc.

Los Gatos, CA · CIK 0001614067

Offering snapshot reported Dec 20, 2022 · SEC filing

Reported sold
$4.85M
Offering amount: $4.85M
Investors reported
1
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Dec 7, 2022
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Dec 20, 2022Initial$4,848,271No comparison1SEC filing
Oct 12, 2022Initial$8,000,000No comparison1SEC filing
Oct 26, 2020Initial$8,429,112No comparison8SEC filing
Dec 15, 2016Initial$13,642,707No comparison14SEC filing
Aug 19, 2016Initial$15,216,241No comparison133SEC filing
Nov 24, 2015Initial$3,000,000No comparison6SEC filing
Jul 17, 2014Initial$3,500,000No comparison9SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-467980

Source: Form D, filed Dec 20, 2022. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Isaac Blech Director
John Borgeson Executive
Robert Coughlin Director
Paul Andre De Lame Executive
Craig Gibbs Director
John Hamilton Director
Fred Kurland Executive
Mike Nazak Executive
Eric Patzer Director
Robert Ruffolo Director
Robert Ruffolo, Jr. Director
Vu Troung Director, Executive
Vu Truong Executive
Susan Windham Bannister Director

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
983 University Avenue Bldg. B
Los Gatos, CA, 95032